Oncology


Eur Rev Med Pharmacol Sci 2021; 25 (20): 6232-6244
DOI: 10.26355/eurrev_202110_26993

Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis

H.J. Lee, G.H. Jeong, H. Li, M.S. Kim, J.S. Kim, S.J. Park, Y.J. Han, K.H. Lee, A. Kronbichler, S.H. Hong, R.A. Ghayda, C. Luchini, A. Nottegar, A. Koyanagi, L. Smith, L. Jacob, E. Dragioti, J. Radua, S. Cargnin, S. Terrazzino, T. Thompson, D.K. Yon, S.W. Lee, J.M. Yang, P. Wasuwanich, J.I. Shin, G. Gamerith
Free PDF Download